Furthermore, simultaneous blockade of programmed cell death-ligand 1(PD-L1) during VSV-M51R treatment achieved remarkable synergistic efficacy in treating monotherapy-resistant late-stage liver metastasis. The gene discussed is CD274; the disease is metastasis.